Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Disease area: Airway diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Nussbaumer-Ochsner, J. Ursprung, C. Siebenmann, M. Maggiorini, K. Bloch (Switzerland). Effect of dexamethasone prophylaxis on sleep and breathing disturbances in high altitude pulmonary edema (HAPE) susceptible subjects after rapid ascent to 4559m. Eur Respir J 2010; 36: Suppl. 54, 982

Member's Comments

No comment yet.

Related content which might interest you: Effect of repeated altitude exposure on nocturnal breathing disturbances in lowlanders. Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers Year: 2017 Effect of dexamethasone on nocturnal breathing in lowlanders with COPD travelling to 3200m Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome Year: 2016 Children at high altitude have less nocturnal periodic breathing than adults Source: Eur Respir J 2008; 32: 189-197 Year: 2008 Dexamethasone and tadalafil prophylaxis prevents both excessive pulmonary constriction and high altitude pulmonary edema in susceptible subjects Source: Eur Respir J 2004; 24: Suppl. 48, 110s Year: 2004 Estimation of effects of intermittent exposure to the altitude of 3200m on hypoxic pulmonary vasoreactivity Source: Eur Respir J 2004; 24: Suppl. 48, 110s Year: 2004 Climbers usually resident at moderate altitude exhibit less oygen desaturation during rapid ascent to 4559 m Source: International Congress 2015 – Clinical exercise physiology in health and disease Year: 2015 Travel to high altitude with pre-existing lung disease Source: Eur Respir J 2007; 29: 770-792 Year: 2007 Effects of acetazolamide on sleep disordered breathing in patients with COPD staying at high altitude. RCT. Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects Year: 2019 Acute mountain sickness is related to nocturnal hypoxemia but not to hypoventilation Source: Eur Respir J 2004; 24: 303-308 Year: 2004 Effect of nocturnal oxygen therapy on daytime pulmonary hemodynamics in patients with COPD travelling to altitude. RCT. Source: Virtual Congress 2021 – Treatments for airway diseases Year: 2021 Inhaled budesonide does not prevent acute mountain sickness after rapid ascent to 4559 m Source: Eur Respir J, 50 (3) 1700982; 10.1183/13993003.00982-2017 Year: 2017 Higher pulmonary artery pressure in children than in adults upon fast ascent to high altitude Source: Eur Respir J 2008; 32: 664-669 Year: 2008 Subclinical pulmonary oedma occurs on ascent to high altitude Source: Eur Respir J 2002; 20: Suppl. 38, 484s Year: 2002 Theophylline and acetazolamide reduce sleep-disordered breathing at high altitude Source: Eur Respir J 2004; 23: 47-52 Year: 2004 High-altitude disease Source: Respipedia Article Year: 2017 Effects of a daytrip to high altitude (2500m) in pulmonary hypertension. Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021 Effect of acute and subacute exposure and reexposure to high altitude on pulmonary artery pressure in healthy lowlanders Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 Nocturnal cerebral oxygenation in patients with COPD at altitude - effect of acetazolamide Source: Virtual Congress 2021 – Hypoxia, exercise and respiratory function in pathophysiological conditions Year: 2021 Polysomnographic nocturnal parameters in high altitude climbers: modulating effects of hypoxia training (HT) versus lower resting ventilation (LRV) Source: Eur Respir J 2006; 28: Suppl. 50, 416s Year: 2006 Effect of altitude on ventilatory pattern in élite climbers during the acclimatization at 5200m Source: Eur Respir J 2005; 26: Suppl. 49, 349s Year: 2005